Articles Archives - AbleChild

AbleChild.org Expands, Media Maverick Joe Hoft Joins Advisory Board

Written by Sheila Matthews on March 25, 2025. Posted in Articles.

Joe Hoft, Author, Media Host
MBA, CPA, CISA, FLMI

March 25, 2025

FOR IMMEDIATE RELEASE:

Wagener, SC 29164, Vero Beach, FL 32963, Milford, CT. 60640
info@ablechild.org, 203.253.0329, www.ablechild.org

AbleChild, a 501(c)(3) nonprofit leading advocacy organization for informed consent and parental rights in mental health, is pleased to announce Joe Hoft as its lead member to the nonprofit Advisory Board.

Joe Hoft brings a wealth of experience to AbleChild’s mission. As an international corporate executive, he has worked around the world for Fortune 500 corporations, overseeing major business functions and financial reporting for multimillion-dollar and billion-dollar entities. His extensive background includes an MBA, CPA, CISA, and FLMI among his ten degrees and designations.

Wyoming Mom’s Fatal Death Rampage Linked to Ketamine, Klonopin Psychiatric Drug Cocktail

Written by Sheila Matthews on March 24, 2025. Posted in Articles.

March, 24, 2025

Tranyelle Harshman, the Byron, Wyoming, mother who killed her four children then herself, was, as expected, on a cocktail of psychiatric mind-altering drugs. The completed toxicology report revealed that Tranyelle was on an anti-anxiety drug and Ketamine at the time of the murder/suicide.

As explained by Tranyelle’s husband, Cliff Harshman, his wife struggled with mental health issues, including depression, post traumatic stress disorder and postpartum depression. The final fatal psychiatric drug prescribed to Tranyelle was Clonazepam (Klonopin), a benzodiazepine, which is a sedative. The possible adverse events associated with the mind-altering drug include sudden confusion and disorientation, feeling paranoid, suicidal thoughts or actions, trouble breathing, new or increased feelings of anxiety, depression, changes in mood or behavior, hallucinations, and losing touch with reality to name a few.

Cleveland Clinic’s Mental Health Practices Under Fire as Court Dismisses Lawsuit

Written by Sheila Matthews on March 22, 2025. Posted in Articles.

March 22, 2025

A recent court decision has put Cleveland Clinic Indian River Hospital’s mental health practices in the spotlight. The Florida appeals court backed the hospital’s request to dismiss a wrongful death lawsuit, but this legal victory has raised more questions than it answered about how the hospital handles mental health emergencies.

The lawsuit stemmed from a tragic incident in March 2022, when 29-year-old Zachary Anderson was fatally shot by deputies while being treated for a mental health crisis at the hospital. While the court’s decision focused on legal technicalities, it has sparked a broader debate about the hospital’s approach to psychiatric care and medication management.

One major concern that has come to light is the apparent lack of reporting to the FDA’s MEDWATCH system. This system is designed to flag dangerous drug reactions, but there’s no evidence that Cleveland Clinic Indian River Hospital uses it for mental health patients. This is worrying, especially considering the hospital’s large-scale psychiatric care operations. They recently took on 2,600 patients needing psychiatric medications after another clinic closed, and they often use strong treatments like electroconvulsive therapy for patients, which is inhumane and has no scientific evidence of curing anything, but scrambles the brain.

Behavioral Health Industry Exploits Untracked Psychiatric Medications with Telehealth on HHS Website

Written by Sheila Matthews on March 21, 2025. Posted in Articles.

March 21, 2025

We are living in a world where children are prescribed mind-altering drugs at alarming rates, but no one tracks the consequences. This isn’t dystopian fiction—it’s happening today. As telehealth surges and is promoted by the US government, the behavioral health industry profits from prescribing dangerous psychiatric drugs to minors without accountability, while families remain powerless to report harms. The consequences of this unchecked industry are stark: systemic failures are now directly infringing on the basic human rights of children.

Every child has the right to protected from harm. Yet the U.S. government does not monitor how many children receive psychiatric drugs via telehealth, despite evidence of widespread off-label use. Adverse reactions like suicidal thoughts, weight gain, or diabetes are underreported, leaving families unaware of risks. Parents often aren’t told that medications are prescribed “off-label” (without FDA approval for children), violating their right to make informed choices. Studies show 55% of children experience serious side effects from antidepressants or antipsychotics, yet fewer than 1% of these cases are reported to systems like MEDWATCH. Without data, families can’t advocate for safer care. Despite the lack of safety protocols, the Department of Health & Human Services (HHS) features it on their website. Maybe the new secretary of the health & human services is unaware of the unequal access that is provided to the industry rather than to consumers on the website via telehealth. It is time for Secretary Kennedy to act by highlighting access to the critical MedWatch drug safety program for the consumers on the HHS website. It is time to demand collection of the appropriate data relating to mind altering psychiatric drugs.

Opioid Settlement Fuels The Psychiatric Industry, Right Back to Big Pharma

Written by Sheila Matthews on March 19, 2025. Posted in Articles.

March 19, 2025

The Opioid Settlement Big Money, Big Business No Drug Safety Funded

In a shocking deep dive, billions of dollars from opioid settlements appear to be strategically redirected back into the pockets of pharmaceutical giants and the behavioral health – psychiatric industry. The settlements, now totaling a staggering $56.9 billion, were meant to address the devastating opioid crisis, but there’s a disturbing lack of oversight on how this money is spent.

At least 70% of the settlement funds must go towards “opioid remediation efforts,” including expanding access to addiction treatments. Here’s the kicker, many of these treatments are psychiatric medications produced by the very same pharmaceutical companies involved in the opioid crisis and will be used on the prison population and mental health courts, which fuels the psychiatric drug and behavioral health industry. Many psychiatric drugs carry blackbox suicide warnings and other deadly side effects. The psychiatric and behavioral health industry must label you in order to qualify for these dangerous unproven solutions. A win/win for the both mega industries.

The Hidden Dose: How Hollywood Normalizes Psychiatric Drugs

Written by Sheila Matthews on March 16, 2025. Posted in Articles.

March 16, 2025

Los Angeles, United States – Photograph taken from Mulholland Drive.

In the dazzling world of entertainment, a subtle yet pervasive issue is spreading. Popular TV shows and movies are quietly embedding psychiatric drugs into everyday narratives, normalizing their use and influencing societal attitudes in ways that are only now becoming clear.

Did the Behavioral Health Industry have Insider Knowledge About the Trump Assassination Attempt in Butler, PA?

Written by Sheila Matthews on March 11, 2025. Posted in Articles.

Photo Credit: Butler, Pennsylvania, July 14. REUTERS/Carlos Osorio

March 11, 2024

AbleChild has been closely following the FBI investigation into the parents of Thomas Crooks, the 20-year-old dead suspect in the attempted assassination of President Trump at a rally in Butler, Pennsylvania, July 13, 2024. Despite no lawsuits or legal actions filed against the Crooks family, the parents have retained Quinn Logue, a high-profile Pittsburgh law firm, raising questions about their involvement and prompting President Trump to call for deeper scrutiny. The FBI is investigating whether Matthew and Mary Crooks had prior knowledge of their son’s plans. How is that going?

HHS Secretary Kennedy Targets Psychiatric Drug Links to Violence

Written by Sheila Matthews on February 24, 2025. Posted in Articles.

February 24, 2025

*Source Medium: Six notable mass shooters in recent American history. (Top row from left to right: Adam Lanza, Nicolas Cruz, Elliot Rogers. Bottom row from left to right: Stephen Paddock, James Holmes)*

Newly confirmed Secretary of the Department of Health and Human Services, Robert Kennedy, Jr., has been assigned the chair of the newly established Make America Healthy Again Commission and, apparently, antidepressants will finally get a much-needed review.

Specifically, Selective Serotonin Reuptake Inhibitors (SSRIs) long have been the antidepressant “treatment” of choice for numerous alleged mental disorders. That’s right…” alleged.” Let’s just get it straight at the beginning so there’s no mistake about what is and is not being “treated.”

There is no science to support any objective, confirmable abnormality, that is any psychiatric diagnosis. That does not mean that people do not experience depression, anxiety, high and lows, etc. It simply means that psychiatric diagnosing is completely subjective, making it difficult, if not impossible, to realistically “treat” a non-existing abnormality. What is being “treated” is a behavior, which is exactly what psychiatry studies…behaviors. Neurologists, not psychiatrists, study diseases (abnormalities) of the brain.